Cincinnati Children’s inks ‘breakthrough’ deal with new-in-town biotech firm

Cincinnati Children’s Hospital and a new-to-town biotech firm are formalizing a collaborative agreement both groups say will help faster develop and spinout research from the medical center into new companies.

Cincinnati Children’s, the region’s largest health system, and Orange Grove Bio, a preclinical drug investment and development firm, said their partnership will advance the development and commercialization of novel therapeutics by supporting the translation of scientific discoveries made by researchers at the medical center. The collaboration, formally announced Wednesday morning, aims to increase entrepreneurship and education as well as boost promising technologies emerging from Cincinnati Children’s.

Click here to read the complete story.

Story excerpt provided by Cincy Inno.

Written by Liz Engel.

Originally published March 9, 2022.